Related Experiment Video
Updated: Aug 8, 2026

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
Published on: September 5, 2025
[Rhabdomyolysis induced by fenofibrate monotherapy]
F Archambeaud-Mouveroux1, S Lopez, C Combes
1Service de Médecine Interne B-d'Endocrinologie, Hôpital du Cluzeau, 23, avenue Dominique-Larrey, 87042 Limoges, France. francoise.archambeaud@chu-limoges.fr
Introduction:
Rhabdomyolysis with fibrate have been reported when fibrate are associated with statin or during renal insufficiency or hypothyroidism.
Case Record:
We describe one patient with diabetes mellitus treated by fenofibrate monotherapy since several years; 48 h after gliclazide therapy was introduced, rhabdomyolysis occurred.
Discussion:
Responsibilities of deshydratation and / or drug interaction with gliclazide. are discussed.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Nephrotic Syndrome I : Introduction
Drug toxicity: Idiosyncratic Reactions
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test